NLM DIR Seminar Schedule
UPCOMING SEMINARS
-
Dec. 8, 2026 Francisco Salvà Serra
Bacterial whole-genome sequencing: a solid ground for infectious disease diagnostics -
Dec. 10, 2026 Roger Karlsson
TBD -
Dec. 15, 2026 Ermin Hodzic
TBD -
Jan. 5, 2027 Vivek Anantharaman
TBD -
Jan. 12, 2027 Oleg Igorevich Obolensky
TBD
RECENT SEMINARS
-
Nov. 16, 2026 Jeremy Miller, PhD
Open access neuroscience data and tools from the Allen Institute and collaborators -
Nov. 3, 2026 Joseph Thole
Using ProteinMPNN to Dissect RfaH CTD Refolding -
Oct. 27, 2026 Bayarbaatar Amgalan
Computational methods to study interactions between tumors and their micro and macro environments -
Oct. 20, 2026 Devlina Chakravarty
Toward Reliable Amyloid Assembly Prediction -
Oct. 13, 2026 Ryan Bell
Satellite Phage Integrated Defensive and Ecotypic Replicons (SPIDERs).
The NLM DIR holds a public weekly seminar series for NLM trainees, staff scientists, and investigators to share details on current and exciting research projects at NLM. Seminars take place on Tuesdays at 11:00 AM, EST and some Thursdays at 3:00 PM, EST. Seminars are held in the B2 Library of Building 38A on the main NIH campus in Bethesda, MD.
To schedule a seminar, click the “Schedule Seminar” button to the right, select an appropriate date on the calendar to sign up, and then complete the form. You will need an NIH PIV card to access the “Schedule Seminar” page.
Please include seminars by invited visiting scientists in the NLM DIR seminar series. These need not be on a Tuesday or Thursday.
If you would like to schedule a seminar by a visiting scientist, click the “Schedule Seminar” and complete the form. Contact NLMDIRSeminarScheduling@mail.nih.gov with questions. Please follow this link to subscribe/unsubscribe to/from the NLM DIR seminar mailing list.
Titles and Abstracts for Upcoming Seminars
(based on the current date)
Bacterial whole-genome sequencing: a solid ground for infectious disease diagnostics
Antimicrobial resistance is increasing the need for faster, more accurate diagnostics and a deeper understanding of how clinically relevant bacteria respond to treatment. In this presentation, Francisco Salvà Serra will discuss how bacterial genomics, metagenomics, and quantitative proteomics can support biomarker discovery, pathogen identification, antimicrobial-resistance surveillance, and the characterization of bacterial responses to antibiotics. Drawing on examples involving Streptococcus pneumoniae, carbapenem-resistant Pseudomonas aeruginosa, and other clinically important bacteria, the presentation will highlight the key role of bacterial genomics both targeted and open-ended approaches, from PCR assay development to real-time nanopore sequencing and mass-spectrometry-based proteomics.
TBD
TBD
TBD
TBD